E-mail: gzliang@cqu.edu.cn    Tel: (86)2365102507

DFBP database
Bioactive Peptide Statistics
Sequence characteristics of all bioactive peptides
Created with Highcharts 6.1.0Amino acidsAmino acid percentage (%)Chart context menuN- and C-terminal amino acid coding featuresTotal peptide sequences: 4719N-TerminalC-terminalQNGSTHDERACMKVLPFYIW02.557.51012.5
The percentage of each amino acid coded at two terminals of different functional peptides
Peptide N-terminal (%) C-terminal (%)
Q N G S T H D E R A C M K V L P F Y I W Q N G S T H D E R A C M K V L P F Y I W
ACE-i 2.35 2.51 7.8 2.99 3.58 3.05 3.15 3.79 4.17 7.48 0.43 2.94 4.76 9.94 12.77 5.88 6.2 6.31 6.89 2.99 5.34 2.24 4.81 2.03 2.62 2.67 1.5 2.94 8.39 4.01 0.43 1.66 8.71 4.01 7.8 19.08 7.96 7.96 1.44 4.38
Renin-i 5.0 2.5 2.5 10.0 2.5 5.0 0.0 7.5 10.0 2.5 0.0 5.0 2.5 2.5 12.5 7.5 7.5 2.5 5.0 7.5 2.5 5.0 5.0 2.5 0.0 5.0 5.0 0.0 17.5 7.5 0.0 0.0 10.0 2.5 12.5 5.0 12.5 7.5 0.0 0.0
Vasorelaxation 25.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 50.0 0.0 0.0 25.0 0.0 0.0 0.0
Antihypertensive 1.1 1.92 7.14 3.85 3.85 1.92 1.92 1.92 7.42 6.32 0.27 4.4 4.67 9.62 11.81 5.49 4.67 8.79 10.71 2.2 3.85 2.2 4.4 1.1 2.2 1.92 1.65 3.3 4.67 3.85 0.55 0.55 5.77 4.4 8.24 21.98 8.52 11.81 0.82 8.24
Vasoconstriction 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 25.0 0.0 0.0 0.0
Antioxidative 3.66 2.47 6.03 4.95 3.46 4.06 3.96 4.45 3.36 7.72 1.48 2.97 4.06 8.51 11.67 5.14 5.04 8.11 4.65 4.25 5.44 3.56 3.36 3.26 3.46 3.96 2.97 5.34 6.33 6.33 1.29 2.47 9.5 3.66 11.28 7.62 5.64 7.91 2.77 3.86
Antimicrobial 6.36 1.32 24.12 4.39 1.75 0.88 2.63 1.54 10.31 6.8 2.41 1.75 5.26 7.68 5.92 1.54 9.21 3.29 2.19 0.66 3.06 1.09 19.91 3.72 0.44 1.09 1.09 1.53 12.69 5.03 14.66 0.44 6.56 2.41 13.13 2.41 3.06 2.84 1.31 3.5
Anticancer 1.87 3.43 19.81 2.34 2.18 1.09 1.72 1.72 9.83 4.99 2.5 2.5 14.04 3.59 6.08 2.03 9.67 2.96 6.08 1.56 2.81 1.56 4.68 3.59 1.4 2.65 2.03 2.18 12.79 3.28 4.21 1.09 21.37 3.43 14.98 3.28 7.18 2.81 2.65 2.03
Antithrombotic 2.98 3.57 13.1 4.17 5.95 5.36 5.95 5.36 7.14 6.55 2.38 2.98 7.14 4.76 6.55 3.57 4.17 2.38 5.36 0.6 3.57 1.79 4.17 2.38 2.38 0.6 1.19 5.36 20.83 4.76 1.79 0.6 23.21 5.36 2.98 7.74 6.55 3.57 1.19 0.0
Antiviral 7.69 0.0 0.0 0.0 0.0 0.0 0.0 7.69 0.0 7.69 0.0 0.0 0.0 0.0 69.23 0.0 0.0 0.0 7.69 0.0 0.0 0.0 7.69 15.38 0.0 0.0 0.0 15.38 0.0 0.0 0.0 0.0 15.38 0.0 23.08 0.0 0.0 7.69 15.38 0.0
DPP IV-i 2.08 0.83 8.75 2.08 5.0 1.25 1.25 4.17 2.5 6.67 0.83 3.75 2.5 10.83 16.25 5.0 5.42 5.0 10.0 5.83 5.83 1.25 5.83 1.25 2.92 1.25 1.67 4.17 4.58 11.25 0.0 2.92 6.67 4.58 15.83 15.42 4.58 5.42 2.92 1.67
α-Amylase-i 4.88 4.88 2.44 4.88 2.44 2.44 7.32 4.88 9.76 14.63 0.0 2.44 2.44 0.0 4.88 21.95 7.32 2.44 0.0 0.0 0.0 4.88 0.0 2.44 0.0 4.88 4.88 0.0 7.32 2.44 4.88 9.76 2.44 0.0 9.76 19.51 14.63 7.32 0.0 4.88
α-Glucosidase-i 4.26 2.13 0.0 4.26 2.13 2.13 6.38 4.26 6.38 8.51 2.13 6.38 10.64 6.38 10.64 6.38 2.13 14.89 0.0 0.0 2.13 6.38 2.13 2.13 0.0 2.13 6.38 4.26 10.64 6.38 0.0 8.51 2.13 0.0 10.64 2.13 17.02 6.38 2.13 8.51
Immunomodulatory 2.94 2.94 4.9 2.94 6.86 0.98 1.96 4.9 11.76 3.92 0.0 1.96 4.9 9.8 6.86 6.86 5.88 6.86 7.84 4.9 2.94 1.96 4.9 0.0 5.88 0.0 0.98 2.94 14.71 0.0 0.98 2.94 9.8 5.88 6.86 10.78 9.8 12.75 3.92 1.96
Opioid 0.0 0.0 5.31 2.65 2.65 0.0 0.0 0.88 4.42 0.88 0.0 0.0 0.88 4.42 4.42 1.77 4.42 66.37 0.0 0.88 5.31 5.31 6.19 1.77 6.19 0.0 0.88 4.42 7.08 5.31 0.0 0.88 2.65 2.65 10.62 12.39 8.85 15.04 2.65 1.77
PEP-i 1.89 0.94 1.89 3.77 1.89 4.72 0.0 5.66 7.55 5.66 0.94 5.66 1.89 11.32 9.43 14.15 3.77 3.77 15.09 0.0 1.89 2.83 0.94 1.89 1.89 2.83 0.0 2.83 2.83 8.49 0.0 0.0 0.94 9.43 2.83 30.19 1.89 8.49 12.26 7.55
Hypocholesterolemic 0.0 0.0 12.5 4.17 0.0 0.0 0.0 0.0 8.33 4.17 0.0 0.0 0.0 16.67 20.83 4.17 0.0 8.33 16.67 4.17 0.0 12.5 0.0 0.0 0.0 4.17 4.17 4.17 12.5 16.67 0.0 0.0 16.67 4.17 4.17 16.67 0.0 4.17 0.0 0.0
Mineral-binding 4.55 9.09 4.55 9.09 0.0 4.55 18.18 4.55 13.64 0.0 0.0 4.55 9.09 9.09 4.55 0.0 4.55 0.0 0.0 0.0 9.09 4.55 0.0 0.0 4.55 4.55 0.0 9.09 4.55 9.09 0.0 4.55 31.82 4.55 4.55 0.0 0.0 9.09 0.0 0.0
Heparin-binding 0.0 5.56 0.0 0.0 0.0 0.0 0.0 5.56 0.0 19.44 0.0 0.0 0.0 0.0 0.0 8.33 38.89 0.0 0.0 22.22 0.0 0.0 0.0 0.0 19.44 5.56 0.0 0.0 0.0 61.11 0.0 0.0 0.0 0.0 0.0 0.0 8.33 0.0 0.0 5.56
Neuropeptide 0.0 7.35 14.71 7.35 2.94 4.41 8.82 4.41 10.29 13.24 1.47 0.0 1.47 4.41 8.82 4.41 2.94 1.47 1.47 0.0 1.47 1.47 1.47 0.0 10.29 0.0 0.0 1.47 2.94 1.47 0.0 0.0 0.0 1.47 10.29 0.0 55.88 1.47 1.47 8.82
Regulating 0.0 0.0 44.44 0.0 11.11 0.0 11.11 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.33 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.11 0.0 0.0 0.0 0.0 0.0 11.11 0.0 22.22 44.44 0.0 11.11
Stimulating 0.0 0.0 4.55 9.09 4.55 0.0 0.0 9.09 4.55 4.55 4.55 0.0 4.55 13.64 18.18 4.55 0.0 4.55 13.64 0.0 9.09 0.0 9.09 4.55 9.09 4.55 0.0 18.18 0.0 0.0 0.0 0.0 0.0 9.09 22.73 4.55 0.0 0.0 9.09 0.0
Ileum contracting 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 10.0 0.0 0.0 0.0 20.0 0.0 40.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Celiac disease 39.76 0.0 1.2 1.2 0.0 0.4 0.0 0.8 0.4 1.61 0.0 0.0 0.0 6.83 5.62 32.13 4.02 2.81 2.01 1.2 39.36 2.41 0.4 2.01 2.41 1.2 0.0 1.61 1.61 2.01 0.0 0.4 0.0 2.41 5.62 8.03 15.26 8.03 6.02 1.2
Cytotoxic 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.29 0.0 0.0 14.29 14.29 14.29 0.0 0.0 0.0 14.29 28.57 0.0 0.0 0.0 0.0 0.0 0.0 28.57 0.0 0.0 0.0 0.0 0.0 0.0 14.29 42.86 0.0 14.29 0.0 0.0 0.0
Haemolytic 0.0 0.0 3.85 7.69 0.0 0.0 0.0 0.0 7.69 0.0 0.0 0.0 0.0 11.54 7.69 0.0 61.54 0.0 0.0 0.0 0.0 0.0 38.46 0.0 3.85 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.08 0.0 23.08 11.54 0.0 0.0
Anxiolytic-like 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.75 0.0 6.25 6.25 6.25 0.0 43.75 6.25 0.0 6.25 0.0 12.5 0.0 12.5 6.25 0.0 0.0 31.25 0.0 0.0 0.0 0.0 6.25 6.25 0.0 0.0 12.5 0.0 6.25
γ-Glutamyl 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.88 0.0 11.76 0.0 5.88 5.88 5.88 5.88 0.0 5.88 5.88 5.88 5.88 5.88 5.88 0.0 5.88 5.88 5.88 5.88
Blood-brain barrier 0.0 0.0 0.0 0.0 0.0 33.33 0.0 8.33 16.67 0.0 16.67 0.0 0.0 0.0 0.0 8.33 0.0 16.67 0.0 0.0 0.0 0.0 33.33 8.33 0.0 0.0 0.0 0.0 8.33 0.0 0.0 0.0 8.33 0.0 25.0 0.0 8.33 8.33 0.0 0.0
Other bioactivity 0.0 0.0 6.67 0.0 0.0 0.0 0.0 13.33 13.33 0.0 0.0 0.0 20.0 13.33 0.0 6.67 0.0 0.0 20.0 6.67 0.0 0.0 6.67 0.0 0.0 0.0 0.0 6.67 20.0 0.0 0.0 0.0 0.0 13.33 6.67 0.0 20.0 0.0 0.0 26.67
Multifunctional 1.44 1.83 7.99 2.88 2.88 2.36 1.97 3.67 6.55 6.55 0.26 3.8 3.8 9.83 11.53 5.77 4.59 10.48 7.86 3.93 4.98 2.1 4.85 1.83 2.1 1.57 1.57 2.75 6.03 4.98 0.66 1.97 9.57 4.06 10.35 16.25 8.39 9.44 2.1 4.46
percentage >= 10%;
7 <= percentage < 10%;
percentage < 7%;
The percentage of amino acid composition encoding different functional peptides
Peptide Amino acid
Q N G S T H D E R A C M K V L P F Y I W
ACE-i 4.39 2.9 7.84 4.06 3.6 2.82 3.11 4.06 4.39 6.52 0.72 1.81 4.88 7.48 9.28 14.88 5.31 5.37 4.45 2.12
Renin-i 2.98 4.76 3.57 5.36 1.19 2.38 6.55 6.55 8.33 3.57 1.19 1.79 4.17 4.17 12.5 6.55 13.69 2.98 4.17 3.57
Vasorelaxation 5.88 11.76 5.88 0.0 0.0 5.88 5.88 0.0 5.88 17.65 5.88 0.0 0.0 11.76 0.0 17.65 5.88 0.0 0.0 0.0
Antihypertensive 3.91 3.32 7.14 4.58 4.22 1.84 2.25 4.45 4.18 5.03 0.63 2.07 4.99 7.64 8.63 15.63 5.12 6.38 5.57 2.43
Vasoconstriction 7.14 0.0 0.0 0.0 7.14 0.0 3.57 7.14 0.0 0.0 10.71 0.0 3.57 10.71 0.0 21.43 14.29 10.71 0.0 3.57
Antioxidative 4.94 3.56 8.56 5.24 3.45 3.63 4.73 6.32 3.83 7.69 1.17 2.14 4.72 6.25 9.28 9.99 3.96 5.16 3.34 2.04
Antimicrobial 3.2 3.21 10.71 5.67 3.53 2.4 2.1 1.87 9.63 6.36 7.84 0.98 8.36 5.25 7.7 6.78 4.52 2.86 5.09 1.93
Anticancer 2.79 2.71 7.66 4.45 2.24 1.97 2.34 2.63 8.88 7.06 2.89 1.35 14.97 5.26 12.82 3.55 4.26 1.86 7.3 3.02
Antithrombotic 5.43 4.6 6.91 6.2 4.03 2.05 6.52 11.57 5.37 7.48 1.15 1.66 6.14 4.86 6.59 8.89 3.39 1.98 4.6 0.58
Antiviral 2.17 1.09 4.35 5.43 2.17 1.09 3.26 13.04 3.26 1.09 6.52 0.0 8.7 3.26 22.83 4.35 0.0 10.87 5.43 1.09
DPP IV-i 4.81 1.63 7.92 2.81 3.92 1.41 3.03 4.22 3.33 7.99 0.74 2.0 3.55 7.18 12.14 19.25 3.4 3.33 5.11 2.22
α-Amylase-i 3.04 4.97 7.46 4.14 1.38 3.59 3.04 2.76 3.04 10.77 4.14 4.97 1.38 4.42 13.26 15.75 6.08 2.21 2.21 1.38
α-Glucosidase-i 5.33 4.27 6.67 5.87 2.67 2.4 3.2 2.67 3.73 11.2 1.6 5.33 4.53 4.53 10.4 11.2 5.87 3.73 3.47 1.33
Immunomodulatory 5.5 3.4 5.5 5.63 6.28 1.18 3.01 5.76 6.54 3.14 0.79 2.36 8.25 6.81 7.46 10.99 5.24 4.58 6.28 1.31
Opioid 2.69 2.43 10.76 4.61 4.23 0.64 0.13 1.54 4.87 2.56 0.77 0.9 1.79 4.99 6.53 17.93 8.83 18.82 2.82 2.18
PEP-i 2.75 2.29 3.21 3.21 3.67 3.55 1.72 4.81 2.29 4.47 0.11 1.15 1.95 7.22 8.02 29.32 5.84 4.47 7.56 2.41
Hypocholesterolemic 2.98 6.55 5.95 2.38 2.98 1.19 4.17 8.33 2.98 8.33 1.19 1.19 4.76 13.69 7.74 12.5 0.6 3.57 7.14 1.79
Mineral-binding 6.82 4.04 3.03 15.4 4.29 2.02 3.28 16.16 2.02 4.55 0.76 3.54 7.32 5.3 3.28 5.81 0.51 3.54 7.83 0.51
Heparin-binding 5.44 1.59 5.22 2.49 2.49 0.45 0.0 0.45 10.2 22.0 6.8 4.54 10.88 2.04 4.99 2.49 4.54 0.0 0.91 12.47
Neuropeptide 1.68 8.12 6.28 5.67 2.91 2.45 2.76 2.91 13.02 5.51 0.31 1.53 2.76 3.52 12.56 6.43 11.79 3.22 3.22 3.37
Regulating 0.0 0.0 17.86 3.57 3.57 0.0 3.57 0.0 3.57 0.0 0.0 0.0 3.57 0.0 28.57 0.0 14.29 17.86 0.0 3.57
Stimulating 19.44 2.78 3.7 8.33 2.78 0.93 0.0 8.33 1.85 5.56 0.93 0.0 1.85 7.41 11.11 15.74 1.85 2.78 4.63 0.0
Ileum contracting 1.3 0.0 5.19 5.19 0.0 1.3 0.0 0.0 14.29 5.19 0.0 5.19 3.9 2.6 15.58 20.78 0.0 14.29 2.6 2.6
Celiac disease 39.68 1.11 2.06 3.78 1.11 0.84 0.24 1.62 1.18 0.98 0.47 0.3 0.24 2.73 4.75 26.16 7.18 3.07 2.16 0.34
Cytotoxic 0.0 5.8 10.14 2.9 4.35 0.0 2.9 1.45 14.49 4.35 7.25 1.45 5.8 8.7 11.59 2.9 2.9 0.0 7.25 5.8
Haemolytic 4.15 0.0 11.35 4.59 1.97 3.93 0.0 0.0 3.06 7.64 0.0 0.66 12.01 3.49 18.34 6.33 9.61 3.71 7.42 1.75
Anxiolytic-like 3.03 0.0 4.55 3.03 4.55 3.03 0.0 3.03 9.09 0.0 0.0 4.55 1.52 3.03 22.73 13.64 0.0 19.7 3.03 1.52
γ-Glutamyl 2.86 0.0 5.71 0.0 2.86 2.86 2.86 51.43 0.0 2.86 2.86 2.86 2.86 5.71 2.86 0.0 2.86 2.86 2.86 2.86
Blood-brain barrier 3.43 3.86 6.87 9.01 3.86 2.15 4.29 3.86 11.59 6.01 1.72 1.72 7.3 3.43 8.58 6.01 3.43 9.01 3.43 0.43
Other bioactivity 7.81 3.13 6.25 1.56 1.56 3.13 3.13 14.06 9.38 0.0 0.0 0.0 7.81 9.38 6.25 7.81 4.69 0.0 6.25 7.81
Multifunctional 4.23 2.88 7.0 4.39 3.02 2.24 2.13 4.43 4.58 6.73 1.16 2.03 5.63 7.33 10.13 13.65 4.99 6.26 4.81 2.36
percentage >= 10%;
7 <= percentage < 10%;
percentage < 7%;
Created with Highcharts 6.1.0Amino acidsAmino acid percentage (%)Chart context menuThe distribution of amino acids, from site 1 to 10 on N-terminal of peptidesTotal peptide sequences: 4719Position 1Position 2Position 3Position 4Position 5Position 6Position 7Position 8Position 9Position 10QNGSTHDERACMKVLPFYIW05101520
Created with Highcharts 6.1.0Amino acidsAmino acid percentage (%)Chart context menuThe distribution of amino acids, from site 1 to 10 on C-terminal of peptidesTotal peptide sequences: 4719Position 1Position 2Position 3Position 4Position 5Position 6Position 7Position 8Position 9Position 10QNGSTHDERACMKVLPFYIW05101520
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214